ICD-10-CM Diagnosis Code A18.2: Tuberculous peripheral lymphadenopathy

ICD-10-CM Diagnosis Code A18.2:Tuberculous peripheral lymphadenopathy

A18.2 is a billable and specific ICD-10-CM code. Accurate documentation of A18.2 facilitates proper diagnosis, effective management, and correct reimbursement.

This guideline will provide the use, official coding guidelines, and historical background of A18.2.

What is the ICD-10-CM Diagnosis Code for Tuberculous peripheral lymphadenopathy?

The ICD-10-CM diagnosis code for Tuberculous peripheral lymphadenopathy is A18.2.

Peripheral lymphadenopathy refers to the swelling of lymph nodes located outside the chest and abdomen, such as in the neck, armpits, or groin. It is usually a sign of infection or inflammation.

Tuberculous peripheral lymphadenopathy is a form of tuberculosis that affects these lymph nodes. It is caused by Mycobacterium tuberculosis. The infection often begins in the lungs and spreads to the lymph nodes.

Symptoms may include painless swelling of nodes, fever, weight loss, and night sweats. It is more common in children and young adults.

Diagnosis involves clinical examination, imaging, and biopsy. Treatment includes a full course of anti-tuberculosis medications. Early treatment helps prevent complications.

Proper documentation using A18.2 ensures patients receive appropriate care and enables accurate healthcare reimbursement.

Applicable for:

  • Tuberculous adenitis

History Background of ICD-10-CM Diagnosis Code A18.2

The ICD-9-CM system, first introduced in 1979, provided the initial framework for coding diseases and health-related conditions in the United States.

The ICD-9-CM diagnosis code for Tuberculous peripheral lymphadenopathy is 017.20.This coding remained consistent from 1979 to 2015.

While the ICD-9-CM system offered a basic approach to disease classification, modern healthcare needs more detail and specificity.

To address this, the ICD-10-CM system was launched in 2015, introducing a more comprehensive and accurate coding structure.

The transition from ICD-9-CM to ICD-10-CM significantly improved the ability to document and analyze conditions such as Tuberculous peripheral lymphadenopathy.

The 2025 edition of ICD-10-CM A18.2 became effective on October 1, 2024.

YearICD-10-CM CodeDescription
2020A18.2No Change
2021A18.2No Change
2022A18.2No Change
2023A18.2No Change
2024A18.2No Change
2025A18.2No Change

Final Thought

Proper coding of A18.2 is essential for diagnosing and managing Tuberculous peripheral lymphadenopathy. A clear understanding of its History, and correct usage enhances medical documentation and ensures effective treatment, patient care, supports healthcare planning, and guarantees proper reimbursement for medical services.

About Author
content writer
Dr. Sehrish Bano, CPB & CPC

As a certified professional in both billing and coding, I specialize in streamlining healthcare revenue cycles and ensuring accurate claim submissions. With more than five years of experience serving the healthcare industry in the USA, I bring expertise in coding accuracy, compliance, and reimbursement optimization. My work focuses on reducing errors, improving efficiency, and supporting providers in delivering quality care without administrative hurdles. I am committed to helping healthcare organizations achieve financial stability and compliance through reliable billing and coding practices.

Table of Contents